Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01303003 · ClinicalTrials.gov registry record · NA
Evaluation of Addition of Dexamethasone to Transversus Abdominis Plane (TAP) Peripheral Nerve Block
A NA study, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01303003 is a NA study that has completed, run by Steward St. Elizabeth's Medical Center of Boston. The registered enrollment target is 24 participants.
The verdict
NCT01303003, a NA study, has completed, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Transversus abdominis plane (TAP) blocks are increasingly being performed after abdominal surgery to provide post operative analgesia. Dexamethasone has demonstrated an ability to prolong the effective duration of analgesia in several different peripheral nerve blocks. The study will examine, in a blinded, prospective and randomized fashion, whether the addition of dexamethasone to TAP blocks similarly prolongs blockade and pain relief. The study will compare local anesthetic with and without the addition of dexamethasone in the TAP block.
Interventions
- DRUG Dexamethasone
- PROCEDURE TAP block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01303003
The ClinicalTrials.gov registry entry for NCT01303003 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Steward St. Elizabeth's Medical Center of Boston, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone is the first listed.
NCT01303003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01303003 about?
NCT01303003 is a clinical study titled "Evaluation of Addition of Dexamethasone to Transversus Abdominis Plane (TAP) Peripheral Nerve Block". Transversus abdominis plane (TAP) blocks are increasingly being performed after abdominal surgery to provide post operative analgesia. Dexamethasone has demonstrated an ability to prolong the effective duration of analgesia in several different peripheral nerve blocks. The study will examine, in a b...
What is the current status of trial NCT01303003?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2010-12. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01303003?
The interventions under investigation include: Dexamethasone (DRUG), TAP block (PROCEDURE).
Who is sponsoring clinical trial NCT01303003?
This trial is sponsored by Steward St. Elizabeth's Medical Center of Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.